Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,907 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Proposal of Quick Diagnostic Criteria for Disseminated Intravascular Coagulation.
Wada H, Yamamoto A, Tomida M, Ichikawa Y, Ezaki M, Masuda J, Yoshida M, Fukui S, Moritani I, Inoue H, Shiraki K, Suzuki K, Imai H, Shimaoka M, Shimpo H. Wada H, et al. Among authors: yoshida m. J Clin Med. 2022 Feb 16;11(4):1028. doi: 10.3390/jcm11041028. J Clin Med. 2022. PMID: 35207302 Free PMC article.
Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection.
Yamamoto A, Wada H, Ichikawa Y, Mizuno H, Tomida M, Masuda J, Makino K, Kodama S, Yoshida M, Fukui S, Moritani I, Inoue H, Shiraki K, Shimpo H. Yamamoto A, et al. Among authors: yoshida m. J Clin Med. 2021 Aug 24;10(17):3775. doi: 10.3390/jcm10173775. J Clin Med. 2021. PMID: 34501223 Free PMC article.
Impact of immune-related adverse events on survival outcomes in extensive-stage small cell lung cancer patients treated with immune checkpoint inhibitors.
Nishimura T, Fujimoto H, Fujiwara T, Ito K, Fujiwara A, Yuda H, Itani H, Naito M, Kodama S, Furuhashi K, Yagi A, Saiki H, Yasuma T, Okano T, Tomaru A, Tanigawa M, Yoshida M, Hataji O, Ibata H, D'Alessandro-Gabazza CN, Gabazza EC, Kobayashi T. Nishimura T, et al. Among authors: yoshida m. Cancer Med. 2024 Apr;13(8):e7188. doi: 10.1002/cam4.7188. Cancer Med. 2024. PMID: 38629295 Free PMC article.
A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.
Maruyama T, Fujisawa T, Okuno M, Toyoshima H, Tsutsui K, Maeda H, Yuda H, Yoshida M, Kobayashi H, Taguchi O, Gabazza EC, Takei Y, Miyashita N, Ihara T, Brito V, Niederman MS. Maruyama T, et al. Among authors: yoshida m. Clin Infect Dis. 2013 Nov;57(10):1373-83. doi: 10.1093/cid/cit571. Epub 2013 Sep 2. Clin Infect Dis. 2013. PMID: 23999080
Community-acquired pneumonia and nursing home-acquired pneumonia in the very elderly patients.
Maruyama T, Gabazza EC, Morser J, Takagi T, D'Alessandro-Gabazza C, Hirohata S, Nakayama S, Ramirez AY, Fujiwara A, Naito M, Nishikubo K, Yuda H, Yoshida M, Takei Y, Taguchi O. Maruyama T, et al. Among authors: yoshida m. Respir Med. 2010 Apr;104(4):584-92. doi: 10.1016/j.rmed.2009.12.008. Epub 2010 Jan 8. Respir Med. 2010. PMID: 20060700 Free article.
A Therapeutic Strategy for All Pneumonia Patients: A 3-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-resistant Pathogens to Select Initial Empiric Therapy.
Maruyama T, Fujisawa T, Ishida T, Ito A, Oyamada Y, Fujimoto K, Yoshida M, Maeda H, Miyashita N, Nagai H, Imamura Y, Shime N, Suzuki S, Amishima M, Higa F, Kobayashi H, Suga S, Tsutsui K, Kohno S, Brito V, Niederman MS. Maruyama T, et al. Among authors: yoshida m. Clin Infect Dis. 2019 Mar 19;68(7):1080-1088. doi: 10.1093/cid/ciy631. Clin Infect Dis. 2019. PMID: 30084884
A Retrospective Comparison of the Clinical Efficacy of Gefitinib, Erlotinib, and Afatinib in Japanese Patients With Non-Small Cell Lung Cancer.
Fujiwara A, Yoshida M, Fujimoto H, Nakahara H, Ito K, Nishihama K, Yasuma T, Hataji O, Taguchi O, D'Alessandro-Gabazza CN, Gabazza EC, Kobayashi T. Fujiwara A, et al. Among authors: yoshida m. Oncol Res. 2018 Aug 23;26(7):1031-1036. doi: 10.3727/096504018X15151523767752. Epub 2018 Jan 10. Oncol Res. 2018. PMID: 29321093 Free PMC article.
Efficacy and Safety of Amrubicin in Small Cell Carcinoma Previously Treated with Immune Checkpoint Inhibitors and Chemotherapy.
Nishimura T, Fujimoto H, Fujiwara T, Ito K, Fujiwara A, Yuda H, Itani H, Naito M, Kodama S, Yagi A, D'Alessandro VF, Yasuma T, Furuhashi K, Saiki H, Okano T, Tomaru A, Tanigawa M, D'Alessandro-Gabazza CN, Gabazza EC, Yoshida M, Hataji O, Ibata H, Kobayashi T. Nishimura T, et al. Among authors: yoshida m. Cancers (Basel). 2022 Aug 16;14(16):3953. doi: 10.3390/cancers14163953. Cancers (Basel). 2022. PMID: 36010946 Free PMC article.
10,907 results
You have reached the last available page of results. Please see the User Guide for more information.